Mounjaro and Wegovy are GLP-1 receptor agonists which have been licensed for weight loss. Ozempic, which is also a GLP-1 receptor agonist which is licensed for diabetes. While these drugs offer significant benefits for blood sugar control and weight management, recent research has raised important questions about their potential link to gallbladder complications, particularly gallstones.
Research indicates that Mounjaro, Wegovy and Ozempic-like medications are associated with an increased risk of gallbladder and biliary disease, including gallstones, but the absolute risk for any one person is generally small.
Read the full article here: https://www.thelondonobesityclinic.co.in/can-the-use-of-mounjaro-wegovy-and-ozempic-cause-gallstones/
